Tocilizumab Reduces Need for Mechanical Ventilation in COVID-19 Pneumonia Trial
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.
General Rheumatology
CDC Removes New COVID-19 Guidelines Few Days After Posting Them
New CDC website guidelines suggesting that the new coronavirus can be transmitted by tiny droplets over a distance greater than six feet and that indoor ventilation is crucial to prevent its spread were removed from the agency’s website late Monday morning.
Aspirin May Be Considered for Primary Prevention of Cardiovascular Disease in Rheumatic Diseases
Study authors reviewed the evidence on the effectiveness of low-dose aspirin in the primary prevention of cardiovascular disease in systemic autoimmune rheumatic diseases.
Predictors of Transition to Adult Rheumatology Care Explored
For pediatric patients transferring to an adult rheumatology clinic, insurance coverage and referral predict shorter time to completed adult visit.
Let’s Talk Women’s Health in Rheumatic Diseases
In this episode, we’re highlighting the importance of recognizing and discussing women’s health – from premenstruation through menstruation and pregnancy and menopausal transition – in rheumatology.
Phenotype of COVID-19-Associated Hyperinflammation Linked to Escalation of Respiratory Support, Survival
Researchers evaluated a specific phenotype of COVID-19-associated hyperinflammation and its association with escalation of patient care.
Lung-Specific Risk Factors Linked to Hip Fracture in Smokers
The addition of lung-specific risk factors into fracture risk assessment tools may more accurately predict hip fracture risk in smokers.
Self-Reported Frailty Prevalent Among Patients With Rheumatic Musculoskeletal Diseases
Researchers described the prevalence of self-reported frailty among patients with rheumatic musculoskeletal diseases and its associated factors.
Digital Health Technologies: The Future of Rheumatology Care
In this episode, we’re taking a deep dive into the role of digital health technologies in rheumatology care and disease management.
![When communicating with patients, it is essential to provide them with key information about their drug regimen, including what the drug is, why they need it, when and how to take it, and for how long they need to take it. [6] They should also be educated about the fluctuating nature of RA, the consequences of nonadherence, and the potential adverse effects associated with their treatment so that they know what to expect and when to call for instruction, reducing the risk of them altering their regimen. [6,10] Because patients of lower socioeconomic status and ethnic minorities are at especially high risk of nonadherence, the RESPECT model of communicating, which has received recognition for improving cultural competence and overall rapport, might be especially beneficial in the RA setting. RESPECT comprises seven core elements: Respect (show), Explain (provide), Support (provide), Power (share), Empathy (show), Concerns (address), and Trust (build). [11]](https://1fxghyessyy2gaob23ygwzph-wpengine.netdna-ssl.com/wp-content/uploads/sites/18/2019/01/5doctorchartcomputerts541_1041336-544x306.jpg)
Rheumatologists Face Challenges in Identifying High-Quality COVID-19 Literature
Study authors highlighted the challenges associated with the identification of published COVID-19 literature and suggested resources for rheumatologists and their patients.
-
Loading...
-
Loading...
Next post in General Rheumatology
